AU2001280591A1 - Modulation of nitric oxide synthase by pkc - Google Patents

Modulation of nitric oxide synthase by pkc

Info

Publication number
AU2001280591A1
AU2001280591A1 AU2001280591A AU8059101A AU2001280591A1 AU 2001280591 A1 AU2001280591 A1 AU 2001280591A1 AU 2001280591 A AU2001280591 A AU 2001280591A AU 8059101 A AU8059101 A AU 8059101A AU 2001280591 A1 AU2001280591 A1 AU 2001280591A1
Authority
AU
Australia
Prior art keywords
pkc
modulation
nitric oxide
oxide synthase
synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280591A
Inventor
George Liang King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
JOSLIN DIABETES CT
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JOSLIN DIABETES CT, Joslin Diabetes Center Inc filed Critical JOSLIN DIABETES CT
Publication of AU2001280591A1 publication Critical patent/AU2001280591A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001280591A 2000-07-18 2001-07-18 Modulation of nitric oxide synthase by pkc Abandoned AU2001280591A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21924600P 2000-07-18 2000-07-18
US60219246 2000-07-18
PCT/US2001/022514 WO2002005810A1 (en) 2000-07-18 2001-07-18 Modulation of nitric oxide synthase by pkc

Publications (1)

Publication Number Publication Date
AU2001280591A1 true AU2001280591A1 (en) 2002-01-30

Family

ID=22818485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280591A Abandoned AU2001280591A1 (en) 2000-07-18 2001-07-18 Modulation of nitric oxide synthase by pkc

Country Status (3)

Country Link
US (2) US20020048581A1 (en)
AU (1) AU2001280591A1 (en)
WO (1) WO2002005810A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492553B1 (en) * 2002-03-14 2006-11-22 DeveloGen Aktiengesellschaft Cg8327 and srm involved in the regulation of energy homeostasis
WO2003084566A2 (en) * 2002-04-10 2003-10-16 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
DE10224750A1 (en) 2002-06-04 2003-12-24 Fresenius Medical Care De Gmbh Device for the treatment of a medical fluid
AU2003274715A1 (en) * 2002-06-10 2003-12-22 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung L(2)44 dea, wunen-2, grapes, cg2221, cg1172, rutabaga, cg11940, facl involved in the regulation of energy homeostasis
WO2004016641A2 (en) * 2002-08-08 2004-02-26 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
US20040176291A1 (en) * 2002-09-24 2004-09-09 Elly Nedivi Methods and compositions for soluble CPG15
ATE545428T1 (en) * 2002-12-16 2012-03-15 Develogen Ag PIK4CB IS INVOLVED IN THE REGULATION OF ENERGY METABOLISM
US20050187175A1 (en) * 2003-09-30 2005-08-25 Elly Nedivi Methods and compositions for CPG15-2
WO2007095113A2 (en) * 2006-02-10 2007-08-23 Massachusetts Institute Of Technology Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
CA2745240A1 (en) 2008-12-04 2010-06-10 Sanofi-Aventis Methods and uses involving heme binding protein 1
US9610392B2 (en) 2012-06-08 2017-04-04 Fresenius Medical Care Holdings, Inc. Medical fluid cassettes and related systems and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors

Also Published As

Publication number Publication date
WO2002005810A1 (en) 2002-01-24
US20040023386A1 (en) 2004-02-05
US20020048581A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2002222252A1 (en) Nitric oxide synthase inhibitor phosphate salt
AU4430599A (en) Inhibitors of nitric oxide synthase
AU2001229501A1 (en) Antisense modulation of inducible nitric oxide synthase expression
GB0031179D0 (en) Nitric oxide synthase inhibitors
AU2001292909A1 (en) Trocar assembly
AU2001275021A1 (en) Trocar assembly
AU2001241142A1 (en) Cyclic compounds
AU2002214303A1 (en) Gene encoding acetolactic acid synthase gene
AU2001287882A1 (en) Nox-trap
AU2001273238A1 (en) Cassette
AU2625201A (en) Glycogen synthase kinase-3 inhibitors
AU2001259265A1 (en) Borehole retention assembly
AU5860501A (en) Oxide based phosphors
AU5248800A (en) Fading inhibitors
AU2001234423A1 (en) Multiblade screwdriver
AU2001280591A1 (en) Modulation of nitric oxide synthase by pkc
AU2002239571A1 (en) Kinases and phosphatases sequences, and use thereof
AU2002304853A1 (en) Substituted benzopyranones as telomerase inhibitors
AU2001282746A1 (en) Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors
AU4452701A (en) Hydrogen getter composition
AU2002343527A1 (en) Telomerase interference
AU2001249723A1 (en) Telomerase inhibitor polynucleotides
AU2001296412A1 (en) Antisense modulation of mekk4 expression
AU2001283302A1 (en) Hydrogen scavengers
AU2002254739A1 (en) Sense amplifier with improved latching